Trials / Withdrawn
WithdrawnNCT00363935
Bariatric Dose-ranging Study With Dexmedetomidine
A Randomized, Double-blind, Controlled Study of Dexmedetomidine (Precedex) Infusion for Improving Control of Acute Autonomic Response During Laparoscopic Bariatric Surgery
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Texas Southwestern Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- —
Summary
After obtaining informed consent,80 morbidly obese ASA II-III patients undergoing laparoscopic bariatric surgery procedures would be randomly assigned to one of four study groups at UTSWMC at Dallas.Hemodynamic paarameters, recovery times, postoperative pain scores, the need for rescue analgesics and side effects will be recorded.The purpose of this study is to determine the optimal linfusion rate of dexmedetomidine for maintaining cardiovscular stability during general anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2006-08-15
- Last updated
- 2019-01-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00363935. Inclusion in this directory is not an endorsement.